{"url_path":"/sec/aemd/8-k/2026-06-04/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-04","source_url":"https://www.sec.gov/Archives/edgar/data/882291/0001683168-26-004540-index.html","accession_number":"0001683168-26-004540","cik":"0000882291","ticker":"AEMD","issuer_name":"AETHLON MEDICAL INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/882291/0001683168-26-004540-index.html","primary_entity_key":"0000882291","primary_entity_name":"AETHLON MEDICAL INC"},"word_count":99,"has_tables":true,"body_markdown":"**Item 9.01.**\n**Financial Statements and Exhibits.**\n\n \n\n(d) Exhibits.\n\n \n\nExhibit No.\n \nDescription\n\n5.1\n \n[Opinion of Procopio Cory Hargreaves & Savitch, LLP](aethlon_ex0501.htm)\n\n23.1\n \nConsent of Procopio Cory Hargreaves & Savitch, LLP (included in [Exhibit 5.1](aethlon_ex0501.htm))\n\n104\n \nCover Page Interactive Data File (embedded within the XBRL document)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 2 \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the\nregistrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nDate: June 4, 2026\n**Aethlon Medical, Inc.**\n\n \n \n \n\n \nBy:\n*/s/ James B. Frakes*\n\n \n\n \n\n \n\nJames B. Frakes\n\nChief Executive Officer and Chief Financial Officer\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n 3"}